EirGenix Statistics
Total Valuation
EirGenix has a market cap or net worth of TWD 25.45 billion. The enterprise value is 21.02 billion.
Market Cap | 25.45B |
Enterprise Value | 21.02B |
Important Dates
The next estimated earnings date is Monday, November 11, 2024.
Earnings Date | Nov 11, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
EirGenix has 306.21 million shares outstanding. The number of shares has increased by 0.45% in one year.
Shares Outstanding | 306.21M |
Shares Change (YoY) | +0.45% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | 1.42% |
Owned by Institutions (%) | 12.44% |
Float | 238.23M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 22.40 |
PB Ratio | 2.62 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -24.96 |
EV / Sales | 18.54 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -14.74 |
Financial Position
The company has a current ratio of 13.25, with a Debt / Equity ratio of 8.69.
Current Ratio | 13.25 |
Quick Ratio | 11.54 |
Debt / Equity | 8.69 |
Debt / EBITDA | n/a |
Debt / FCF | -0.59 |
Interest Coverage | -123.65 |
Financial Efficiency
Return on equity (ROE) is -8.40% and return on invested capital (ROIC) is -6.15%.
Return on Equity (ROE) | -8.40% |
Return on Assets (ROA) | -5.93% |
Return on Capital (ROIC) | -6.15% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.10 |
Inventory Turnover | 1.16 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.36% in the last 52 weeks. The beta is 0.62, so EirGenix's price volatility has been lower than the market average.
Beta (5Y) | 0.62 |
52-Week Price Change | -11.36% |
50-Day Moving Average | 86.42 |
200-Day Moving Average | 89.67 |
Relative Strength Index (RSI) | 43.30 |
Average Volume (20 Days) | 316,627 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EirGenix had revenue of TWD 1.13 billion and -842.30 million in losses. Loss per share was -2.76.
Revenue | 1.13B |
Gross Profit | 256.07M |
Operating Income | -1.05B |
Pretax Income | -840.58M |
Net Income | -842.30M |
EBITDA | -788.58M |
EBIT | -1.05B |
Loss Per Share | -2.76 |
Balance Sheet
The company has 5.27 billion in cash and 843.05 million in debt, giving a net cash position of 4.42 billion or 14.44 per share.
Cash & Cash Equivalents | 5.27B |
Total Debt | 843.05M |
Net Cash | 4.42B |
Net Cash Per Share | 14.44 |
Equity (Book Value) | 9.70B |
Book Value Per Share | 31.67 |
Working Capital | 6.10B |
Cash Flow
In the last 12 months, operating cash flow was -593.56 million and capital expenditures -832.82 million, giving a free cash flow of -1.43 billion.
Operating Cash Flow | -593.56M |
Capital Expenditures | -832.82M |
Free Cash Flow | -1.43B |
FCF Per Share | -4.66 |
Margins
Gross margin is 22.58%, with operating and profit margins of -92.82% and -74.27%.
Gross Margin | 22.58% |
Operating Margin | -92.82% |
Pretax Margin | -74.12% |
Profit Margin | -74.27% |
EBITDA Margin | -69.53% |
EBIT Margin | -92.82% |
FCF Margin | -125.77% |
Dividends & Yields
EirGenix does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.45% |
Shareholder Yield | -0.45% |
Earnings Yield | -3.32% |
FCF Yield | -5.61% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |